{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039557","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.841001+00:00","generated_at":"2026-06-08T20:58:21.440942+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biotricity issues $1M convertible note with 12% interest, 18-month maturity","bullets":["Issued $1,000,000 unsecured convertible preferred note to an investor.","Note bears 12% annual interest, payable monthly in cash.","Maturity 18 months; prepayable at 15% discount to 10-day VWAP; conversion at 20% discount to Qualified Financing price or 15% discount to VWAP at maturity.","Note issued in reliance on Section 4(a)(2) exemption from registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039557","json":"https://secwatch.observer/filing/0001493152-23-039557.json","markdown":"https://secwatch.observer/filing/0001493152-23-039557.md","text":"https://secwatch.observer/filing/0001493152-23-039557.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/0001493152-23-039557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T20:58:21.440942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c6e9c47e487b5c1c8f7775b257edb810746a5b52","claim":"BIOTRICITY INC. incurred convertible notes of $1,000,000 at 12% per annum maturing the earlier of 18 months or the 18 month anniversary of the last closing date.","evidence_excerpt":"On October 31, 2023, Biotricity Inc. (the “Company”) entered into a subscription agreement (the “Agreement”) pursuant to which the Company issued an unsecured convertible preferred note (the “Note”) in the principal amount of $1,000,000 to an investor (“Investor”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/0001493152-23-039557-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1,000,000"},{"label":"Rate","value":"12% per annum"},{"label":"Maturity","value":"the earlier of 18 months or the 18 month anniversary of the last closing date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"6b0ff1d2aa1eeaa5cee4ac2f194331cf0d9e3694","claim":"BIOTRICITY INC. entered into Agreement valued at $1,000,000 (effective 2023-10-31).","evidence_excerpt":"On October 31, 2023, Biotricity Inc. (the “Company”) entered into a subscription agreement (the “Agreement”) pursuant to which the Company issued an unsecured convertible preferred note (the “Note”) in the principal amount of $1,000,000 to an investor (“Investor”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223039557/0001493152-23-039557-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Value","value":"$1,000,000"},{"label":"Effective","value":"2023-10-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}